STEPHENSON BRIAN C — SEC Form 4 filings
SEC reporting owner CIK 1780030. 13 Form 4 filings on record with FilingPulse; latest filed 2026-07-01.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-02-21 to 2026-07-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 22 legs across 3 filings — 46,688 shares, $1,133,317 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 7 legs across 5 filings — 88,959 shares, $3,095,575 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 39.
- Largest priced transaction: sale of 68,000 shares @ $36.29 ($2,467,761) in BridgeBio Pharma, Inc., filed 2025-01-30.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | CFO and Treasurer | 10 | — | 7 legs · 88,959 sh · $3,095,575 | 39 |
| Faeth Therapeutics, Inc. (FTH) | Chief Financial Officer | 3 | 22 legs · 46,688 sh · $1,133,317 | — | — |
Form 4 filings — STEPHENSON BRIAN C
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-01 | 4 | Faeth Therapeutics, Inc. (FTH) | Purchase (P): 831 @ $23.34 · Purchase (P): 1,910 @ $22.95 · Purchase (P): 1,638 @ $23.88 · Purchase (P): 4,255 @ $24.98 · Purchase (P): 4,400 @ $23.40 · Purchase (P): 600 @ $24.22 | EDGAR |
| 2026-06-26 | 4 | Faeth Therapeutics, Inc. (FTH) | Purchase (P): 2,891 @ $25.22 · Purchase (P): 3,000 @ $25.98 · Purchase (P): 3,400 @ $26.98 · Purchase (P): 100 @ $27.77 · Purchase (P): 580 @ $23.61 · Purchase (P): 4,212 @ $24.90 · +2 more | EDGAR |
| 2026-06-24 | 4 | Faeth Therapeutics, Inc. (FTH) | Purchase (P): 1,797 @ $20.23 · Purchase (P): 1,118 @ $20.82 · Purchase (P): 1,583 @ $22.40 · Purchase (P): 3,329 @ $23.28 · Purchase (P): 356 @ $23.95 · Purchase (P): 6,836 @ $24.12 · +2 more | EDGAR |
| 2025-02-27 | 4 | BridgeBio Pharma, Inc. (BBIO) | Option exercise (M): 8,500 @ $17 · Sale (S): 8,400 @ $33.18 · Sale (S): 100 @ $34.18 · Option exercise (M): 8,500 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | BridgeBio Pharma, Inc. (BBIO) | Option exercise (M): 25,798 · Tax withholding (F): 13,102 @ $34.90 · Sale (S): 4,148 @ $36.16 · Option exercise (M): 779 (derivative) @ $0 · Option exercise (M): 946 (derivative) @ $0 · Option exercise (M): 17,368 (derivative) @ $0 · +1 more | EDGAR |
| 2025-01-30 | 4 | BridgeBio Pharma, Inc. (BBIO) | Option exercise (M): 68,000 @ $17 · Sale (S): 68,000 @ $36.29 · Option exercise (M): 68,000 (derivative) @ $0 | EDGAR |
| 2024-12-12 | 4 | BridgeBio Pharma, Inc. (BBIO) | Grant/award (A): 42,683 (derivative) @ $0 | EDGAR |
| 2024-11-20 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 4,156 @ $22.41 | EDGAR |
| 2024-11-19 | 4 | BridgeBio Pharma, Inc. (BBIO) | Option exercise (M): 25,799 · Tax withholding (F): 13,077 @ $23.72 · Option exercise (M): 778 (derivative) @ $0 · Option exercise (M): 947 (derivative) @ $0 · Option exercise (M): 17,369 (derivative) @ $0 · Option exercise (M): 6,705 (derivative) @ $0 | EDGAR |
| 2024-08-20 | 4 | BridgeBio Pharma, Inc. (BBIO) | Option exercise (M): 25,797 · Tax withholding (F): 13,077 @ $24.40 · Sale (S): 2,457 @ $24.39 · Sale (S): 1,698 @ $25.13 · Option exercise (M): 778 (derivative) @ $0 · Option exercise (M): 946 (derivative) @ $0 · +2 more | EDGAR |
| 2024-05-17 | 4 | BridgeBio Pharma, Inc. (BBIO) | Option exercise (M): 27,507 · Tax withholding (F): 13,943 @ $31.04 · Option exercise (M): 1,710 (derivative) @ $0 · Option exercise (M): 778 (derivative) @ $0 · Option exercise (M): 947 (derivative) @ $0 · Option exercise (M): 17,368 (derivative) @ $0 · +1 more | EDGAR |
| 2024-03-14 | 4 | BridgeBio Pharma, Inc. (BBIO) | Grant/award (A): 15,442 (derivative) @ $0 · Grant/award (A): 107,278 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | BridgeBio Pharma, Inc. (BBIO) | Option exercise (M): 44,996 · Tax withholding (F): 18,919 @ $37.21 · Option exercise (M): 1,710 (derivative) @ $0 · Option exercise (M): 778 (derivative) @ $0 · Option exercise (M): 24,193 (derivative) @ $0 · Option exercise (M): 946 (derivative) @ $0 · +1 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1780030 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →